Tech Company Financing Transactions
Gen9 Funding Round
Gen9 closed a $1.6 million Series B financing round on 9/9/2011. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/9/2011
Transaction Type
Venture Equity
Amount
$1,550,001
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount reflects value of Series B Preferred Stock to be sold & Series B Preferred Stock underlying Warrants and Promissory Notes. Amount Sold reflects value of Preferred Stock sold. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr. 5th Floor
Cambridge, MA 01239
USA
Cambridge, MA 01239
USA
Phone
Website
Email Address
Overview
Don t waste time picking colonies. Gen9 s innovative process provides sequence-perfect, clonal gene synthesis products at the best price in the industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Munnelly
Chief Financial Officer
David Stone
VP - Bus. Development
Aaron Zucker
VP - Marketing
Leda Notchey
VP - R & D
Devin Leake
Browse more venture capital transactions:
Prev: 9/9/2011: Fingerprint venture capital transaction
Next: 9/9/2011: PresenceLearning venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs